FIELD: medicine; ophthalmology.
SUBSTANCE: essence of the invention is glycosaminoglycans content determination in patient's blood plasma in acute period of eye lesion in Reiter's syndrome. If glycosaminoglycans level in blood plasma is less than 16 mcg/ml, then recurrent course of disease can be forecasted. If glycosaminoglycans concentration in blood plasma is higher than 21.5 mcg/ml, course of disease can be estimated as favourable, without relapses.
EFFECT: improvement of clinical course frequency prognosis in eye lesion and early stage prognostics of eye disease clinical course.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING CLINICAL COURSE OF CHLAMIDIA CONJUNCTIVITIS | 2004 |
|
RU2264627C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF BACTERIAL CONJUNCTIVITIS | 2011 |
|
RU2446399C1 |
| METHOD FOR PREDICTING UVEITIS DEVELOPMENT COURSE IN THE CASES OF SYSTEMIC OR SYNDROMIC DISEASES | 1999 |
|
RU2157541C1 |
| METHOD FOR PREDICTION OF TRANSITION FROM ACUTE BACTERIAL CONJUNCTIVITIS TO SUBACUTE OR CHRONIC CLINICAL COURSE | 2011 |
|
RU2450271C1 |
| METHOD FOR TREATING OPHTHALMIC MANIFESTATIONS OF DISEASES TRANSMITTED VIA SEXUAL INTERCOURSE | 2003 |
|
RU2259180C2 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF MYOCARDIAL INFARCTION COMPLICATION | 2008 |
|
RU2373542C1 |
| METHOD FOR PREDICTING ACUTE FLOW OF CHLAMYDIAL CONJUNCTIVITIS | 2004 |
|
RU2281503C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF AUTOIMMUNE OPHTHALMOPATHY IN DIFFUSE TOXIC GOITER PATIENTS | 2006 |
|
RU2309404C1 |
| METHOD FOR FORECASTING THE UVEITIS CLINICAL COURSE | 0 |
|
SU1747064A1 |
| METHOD OF PREDICTING COURSE OF ADENOVIRAL KERATOCONJUNCTIVITIS | 2011 |
|
RU2470591C1 |
